Skip to main content
. 2018 Oct 25;9:1486. doi: 10.3389/fphys.2018.01486

Figure 2.

Figure 2

Correlation of HOMA-IR with magnitude of change in burst incidence and burst frequency in Moxonidine vs. placebo group. In the moxonidine group, reduction in burst incidence (A) and burst frequency (B) correlated with HOMA-IR at baseline. There was no correlation of change in MSNA with baseline HOMA-IR in the placebo group (C,D).